CYP2B6 and metabolic dysfunction-associated steatotic liver disease: Similarly, P4504F2a protein levels mirror the mRNA results (Figures 6B, C), suggesting that the CYP4F2a P450 is not a significant contributor to 20-HETE levels in the progression of MASLD (Figures 3A, B).